Drug Shortage Report for ENGERIX-B

Last updated on 2019-12-10 History
Report ID 6511
Drug Identification Number 01919431
Brand name ENGERIX B INJ SUS 20MCG/ML
Common or Proper name Hepatitis B vaccine (recombinant)
Company Name GLAXOSMITHKLINE INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) HEPATITIS B SURFACE ANTIGEN
Strength(s) 20MCG
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR
Packaging size 1's
ATC code J07BC
ATC description VIRAL VACCINES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2017-04-06
Estimated end date
Actual end date 2019-12-09
Shortage status Resolved
Updated date 2019-12-10
Company comments
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v35 2019-01-23 English Compare
v34 2019-01-11 French Compare
v33 2019-01-11 English Compare
v32 2018-12-03 French Compare
v31 2018-12-03 English Compare
v30 2018-11-02 French Compare
v29 2018-11-02 English Compare
v28 2018-09-13 French Compare
v27 2018-09-13 English Compare
v26 2018-08-22 French Compare
v25 2018-08-22 English Compare
v24 2018-06-13 French Compare
v23 2018-06-13 English Compare
v22 2018-04-25 French Compare
v21 2018-04-25 English Compare
v20 2018-02-20 French Compare
v19 2018-02-20 English Compare
v18 2018-02-08 French Compare
v17 2018-02-08 English Compare
v16 2018-01-25 French Compare

Showing 21 to 40 of 55